His primary areas of investigation include Psychiatry, Bipolar disorder, Placebo, Internal medicine and Pediatrics. His research integrates issues of Randomized controlled trial and Clinical psychology in his study of Psychiatry. His study looks at the intersection of Clinical psychology and topics like Mental health with Medical prescription and Aggression.
His work carried out in the field of Bipolar disorder brings together such families of science as Comorbidity, Mood disorders and Mood. His research in Placebo intersects with topics in Methylphenidate, Attention deficit hyperactivity disorder, Tolerability and Clinical trial. His studies in Pediatrics integrate themes in fields like Risperidone, Pharmacotherapy, Somnolence and Rating scale.
Robert L. Findling spends much of his time researching Psychiatry, Clinical psychology, Bipolar disorder, Attention deficit hyperactivity disorder and Placebo. His Psychiatry study typically links adjacent topics like Internal medicine. Robert L. Findling focuses mostly in the field of Clinical psychology, narrowing it down to matters related to Psychosocial and, in some cases, Psychological intervention.
His study looks at the relationship between Bipolar disorder and topics such as Pediatrics, which overlap with Risperidone. The Attention deficit hyperactivity disorder study combines topics in areas such as Anesthesia, Lisdexamfetamine Dimesylate, Stimulant and Rating scale. The various areas that Robert L. Findling examines in his Placebo study include Randomized controlled trial, Discontinuation and Clinical trial.
Psychiatry, Clinical psychology, Pediatrics, Bipolar disorder and Attention deficit hyperactivity disorder are his primary areas of study. Robert L. Findling works mostly in the field of Psychiatry, limiting it down to topics relating to Placebo-controlled study and, in certain cases, Internal medicine, as a part of the same area of interest. His Clinical psychology research is multidisciplinary, relying on both Mental health, Mania and Aggression.
His Pediatrics study combines topics in areas such as Insomnia, Clinical trial, Adverse effect, Autism and Comorbidity. The concepts of his Bipolar disorder study are interwoven with issues in Lithium and Family history. His Attention deficit hyperactivity disorder study integrates concerns from other disciplines, such as Emotional dysregulation and Viloxazine.
His scientific interests lie mostly in Psychiatry, Placebo, Clinical psychology, Bipolar disorder and Attention deficit hyperactivity disorder. Robert L. Findling has included themes like Internal medicine, Adverse effect, Pediatrics and Rating scale in his Placebo study. In his research on the topic of Internal medicine, Mental illness is strongly related with Schizophrenia.
The study incorporates disciplines such as Psychosocial, Diagnostic accuracy, Schedule for Affective Disorders and Schizophrenia and Anterior cingulate cortex in addition to Clinical psychology. He has researched Bipolar disorder in several fields, including Reliability, Lithium and Prefrontal cortex. His study in Attention deficit hyperactivity disorder is interdisciplinary in nature, drawing from both Emotional dysregulation, Developmental psychology, Ventrolateral prefrontal cortex, Psychophysiological Interaction and Amygdala.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia
Tom Walsh;Jon M. McClellan;Shane E. McCarthy;Anjené M. Addington.
A fluid percussion model of experimental brain injury in the rat
C. E. Dixon;Bruce G Lyeth;J. T. Povlishock;R. L. Findling.
Journal of Neurosurgery (1987)
The Treatment for Adolescents with Depression Study (TADS): Long-term effectiveness and safety outcomes
John S. March;Susan Silva;Stephen Petrycki;John Curry.
Archives of General Psychiatry (2007)
Treatment guidelines for children and adolescents with bipolar disorder
Robert A Kowatch;Mary Fristad;Boris Birmaher;Karen Dineen Wagner.
Journal of the American Academy of Child and Adolescent Psychiatry (2005)
The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders
Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen.
American Journal of Psychiatry (2013)
Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.
Randall Owen;Linmarie Sikich;Ronald N. Marcus;Patricia Corey-Lisle.
Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study
Linmarie Sikich;Jean A. Frazier;Jon McClellan;Robert L. Findling.
American Journal of Psychiatry (2008)
Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence
Michael G. Aman;Goedele De Smedt;Albert Derivan;Ben Lyons.
American Journal of Psychiatry (2002)
Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder.
Jon McClellan;Robert Kowatch;Robert L. Findling.
Journal of the American Academy of Child and Adolescent Psychiatry (2007)
Validation of Proposed DSM-5 Criteria for Autism Spectrum Disorder
Thomas W. Frazier;Eric Arden Youngstrom;Leslie Speer;Rebecca Embacher.
Journal of the American Academy of Child and Adolescent Psychiatry (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: